These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 35038898)

  • 1. Human Nasal Epithelial Cells Sustain Persistent SARS-CoV-2 Infection
    Gamage AM; Tan KS; Chan WOY; Lew ZZR; Liu J; Tan CW; Rajagopalan D; Lin QXX; Tan LM; Venkatesh PN; Ong YK; Thong M; Lin RTP; Prabhakar S; Wang Y; Wang LF
    mBio; 2022 Feb; 13(1):e0343621. PubMed ID: 35038898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of late-onset antiviral treatment in immunocompromised hosts with persistent SARS-CoV-2 infection.
    Lieber CM; Kang H-J; Sobolik EB; Sticher ZM; Ngo VL; Gewirtz AT; Kolykhalov AA; Natchus MG; Greninger AL; Suthar MS; Plemper RK
    J Virol; 2024 Sep; 98(9):e0090524. PubMed ID: 39207133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Infection of human Nasal Epithelial Cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles.
    Gamage AM; Tan KS; Chan WOY; Liu J; Tan CW; Ong YK; Thong M; Andiappan AK; Anderson DE; Wang Y; Wang LF
    PLoS Pathog; 2020 Dec; 16(12):e1009130. PubMed ID: 33284849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein Coding and Long Noncoding RNA (lncRNA) Transcriptional Landscape in SARS-CoV-2 Infected Bronchial Epithelial Cells Highlight a Role for Interferon and Inflammatory Response.
    Vishnubalaji R; Shaath H; Alajez NM
    Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32646047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 infection alters mitochondrial and cytoskeletal function in human respiratory epithelial cells mediated by expression of spike protein.
    Yeung-Luk BH; Narayanan GA; Ghosh B; Wally A; Lee E; Mokaya M; Wankhade E; Zhang R; Lee B; Park B; Resnick J; Jedlicka A; Dziedzic A; Ramanathan M; Biswal S; Pekosz A; Sidhaye VK
    mBio; 2023 Aug; 14(4):e0082023. PubMed ID: 37504520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of late-onset antiviral treatment in immune-compromised hosts with persistent SARS-CoV-2 infection.
    Lieber CM; Kang HJ; Sobolik EB; Sticher ZM; Ngo VL; Gewirtz AT; Kolykhalov AA; Natchus MG; Greninger AL; Suthar MS; Plemper RK
    bioRxiv; 2024 May; ():. PubMed ID: 38826222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrinsic factors behind long COVID: III. Persistence of SARS-CoV-2 and its components.
    El-Baky NA; Amara AA; Uversky VN; Redwan EM
    J Cell Biochem; 2024 Jan; 125(1):22-44. PubMed ID: 38098317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters.
    Chan JFW; Poon VKM; Chan CCS; Chik KKH; Tsang JOL; Zou Z; Chan CCY; Lee ACY; Li C; Liang R; Cao J; Tang K; Yuen TTT; Hu B; Huang X; Chai Y; Shuai H; Luo C; Cai JP; Chan KH; Sridhar S; Yin F; Kok KH; Chu H; Zhang AJ; Yuan S; Yuen KY
    Clin Infect Dis; 2022 Aug; 75(1):e1101-e1111. PubMed ID: 34536277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19.
    Ziegler CGK; Miao VN; Owings AH; Navia AW; Tang Y; Bromley JD; Lotfy P; Sloan M; Laird H; Williams HB; George M; Drake RS; Christian T; Parker A; Sindel CB; Burger MW; Pride Y; Hasan M; Abraham GE; Senitko M; Robinson TO; Shalek AK; Glover SC; Horwitz BH; Ordovas-Montanes J
    bioRxiv; 2021 Feb; ():. PubMed ID: 33619488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
    Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
    J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ColdZyme Maintains Integrity in SARS-CoV-2-Infected Airway Epithelia.
    Posch W; Vosper J; Zaderer V; Noureen A; Constant S; Bellmann-Weiler R; Lass-Flörl C; Wilflingseder D
    mBio; 2021 Apr; 12(2):. PubMed ID: 33906927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long COVID brain fog and muscle pain are associated with longer time to clearance of SARS-CoV-2 RNA from the upper respiratory tract during acute infection.
    Antar AAR; Yu T; Demko ZO; Hu C; Tornheim JA; Blair PW; Thomas DL; Manabe YC
    Front Immunol; 2023; 14():1147549. PubMed ID: 37187756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 ORF8 Forms Intracellular Aggregates and Inhibits IFNγ-Induced Antiviral Gene Expression in Human Lung Epithelial Cells.
    Geng H; Subramanian S; Wu L; Bu HF; Wang X; Du C; De Plaen IG; Tan XD
    Front Immunol; 2021; 12():679482. PubMed ID: 34177923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
    Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
    Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells.
    Tandel D; Sah V; Singh NK; Potharaju PS; Gupta D; Shrivastava S; Sowpati DT; Harshan KH
    Microbiol Spectr; 2022 Oct; 10(5):e0160422. PubMed ID: 36073824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune Responses and Pathogenesis following Experimental SARS-CoV-2 Infection in Domestic Cats.
    Vreman S; van der Heijden EMDL; Ravesloot L; Ludwig IS; van den Brand JMA; Harders F; Kampfraath AA; Egberink HF; Gonzales JL; Oreshkova N; Broere F; van der Poel WHM; Gerhards NM
    Viruses; 2023 Apr; 15(5):. PubMed ID: 37243138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 Detection and Culture in Different Biological Specimens from Immunocompetent and Immunosuppressed COVID-19 Patients Infected with Two Different Viral Strains.
    Mendes-Correa MC; Salomão MC; Ghilardi F; Tozetto-Mendoza TR; Santos Villas-Boas L; de Paula AV; Paiao HGO; da Costa AC; Leal FE; Ferraz ABC; Sales FCS; Claro IM; Ferreira NE; Pereira GM; da Silva AR; Freire W; Espinoza EPS; Manuli ER; Romano CM; de Jesus JG; Sabino EC; Witkin SS
    Viruses; 2023 May; 15(6):. PubMed ID: 37376568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection.
    Schuhenn J; Meister TL; Todt D; Bracht T; Schork K; Billaud JN; Elsner C; Heinen N; Karakoese Z; Haid S; Kumar S; Brunotte L; Eisenacher M; Di Y; Lew J; Falzarano D; Chen J; Yuan Z; Pietschmann T; Wiegmann B; Uebner H; Taube C; Le-Trilling VTK; Trilling M; Krawczyk A; Ludwig S; Sitek B; Steinmann E; Dittmer U; Lavender KJ; Sutter K; Pfaender S
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35131898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.